Steven Shoptaw PhD is a licensed psychologist and Director of the Center for Behavioral and Addiction Medicine. Dr. Shoptaw is Professor in Family Medicine and Psychiatry and Biobehavioral Sciences and Vice Chair for Research in Family Medicine. From these contexts, Dr. Shoptaw conducts a portfolio of research that focuses on the medical treatment of addiction and of HIV prevention in the context of addiction. The research Dr. Shoptaw conducts is translational, meaning he works with basic science researchers and with clinicians to study the ways that drugs of abuse, especially methamphetamine, affects biological processes relevant to HIV transmission.
Dr. Shoptaw energetically maintains research, clinical and policy efforts to bring novel and high impact solutions to delivering culturally competent care for persons affected by addictions and HIV. This often means developing innovative solutions that address consistent barriers to accessing structural and social determinants of health faced by people living with these interwoven health problems. These solutions have ranged from developing housing solutions for homeless persons living with HIV and concomitant substance use or mental health disorder (Safe House) to evaluating the impact of using a mobile medical unit to initiate and maintain medications for opioid use disorder for persons who inject opioids and are living with HIV in 5 U.S. cities (HPTN 094). Dr. Shoptaw is active within the Los Angeles County area in working with policymakers, scientists and agency leaders to develop and evaluate initiatives to optimize impacts of HIV prevention and addiction investments. In addition to his extensive research portfolio, Dr Shoptaw maintains a limited clinical psychology practice at UCLA, treating patients with severe substance use and mental health disorders.
Department of Family Medicine
10880 Wilshire Blvd, Suite 1800
Los Angeles, CA 90024
Addiction Treatment, HIV, and the intersection of the two.
Steven Shoptaw, PhD is a licensed psychologist and Director of the Center for Behavioral and Addiction Medicine at UCLA. He is a Professor in the UCLA Departments of Family Medicine and Psychiatry and Biobehavioral Sciences and is Vice Chair of Research in Family Medicine. He also holds an honorary appointment at the University of Cape Town. Dr. Shoptaw has a portfolio of work that focuses on the treatment of addiction and HIV prevention in the context of addiction in the Western U.S. where stimulant use is the single strongest predictor of HIV transmission. For over 25 years, Dr. Shoptaw has conducted a series of clinical studies in community settings that address these topics. He currently serves as Co-Principal Investigator of the NIDA Clinical Trials Network Big South-West Node where he leads development of clinical trials to treat stimulant dependence. He is Principal Investigator and Director of the Center for HIV Identification, Prevention and Treatment Services (CHIPTS) which promotes collaborative research, fosters networking, and supports capacity building among communities and agency partners in efforts to eliminate new HIV infections and health disparities among key populations with HIV-associated comorbidities. He is also Co-Principal Investigator of an cohort study that seeks to understand how drug use affects the immune system of HIV-positive and HIV-negative men who have sex with men (MSM). He previously served on the Executive Committee of the HIV Prevention Trials Network, helping set priorities and direct the network's scientific agenda and he is currently protocol chair for a study of integrated strategies for linking persons with opioid use disorder to care and prevention for addiction, HIV, HCV and to primary care. Dr. Shoptaw has on-going international collaborations with academic partners in Cape Town, South Africa and Hanoi, Vietnam taking proven strategies that have worked in the U.S. and adapting them to fit the needs in each country.
- Shoptaw Steven, Heinzerling Keith G, Rotheram-Fuller Erin, Steward Trevor, Wang Jason, Swanson Aimee-Noelle, De La Garza Richard, Newton Tom, Ling Walter Randomized, placebo-controlled trial of bupropion for the treatment of methamphetamine dependence.. Drug and Alcohol Dependence. 2008; 96(3): 222-32.
- Shoptaw Steven, Reback Cathy J., Larkins Sherry, Wang Jason, Rotheram-Fuller Erin, Dang Jeff, Yang Xiaowei Outcomes using two tailored behavioral treatments for substance abuse in urban gay and bisexual men.. Journal of Substance Abuse Treatment. 2008; 27(15).
- King William, Larkins Sherry, Hucks-Ortiz Christopher, Wang Jason, Gorbach Pamina, Veniegas Rosemary, Shoptaw Steven Factors Associated with HIV Viral Load in a Respondent Driven Sample in Los Angeles. AIDS and behavior. 2007; 92(1-3).
- Okafor CN, Hucks-Ortiz C, Hightow-Weidman LB, Magnus M, Emel L, Beauchamp G, Kuo I, Hendrix C, Mayer KH, Shoptaw SJ. Brief Report: Associations Between Self-Reported Substance Use Behaviors and PrEP Acceptance and Adherence Among Black MSM in the HPTN 073 Study. J Acquir Immune Defic Syndr. 2020 Sep 1;85(1):23-29. PMCID: PMC7429251
- Shoptaw S, Landovitz RJ, Reback CJ. Contingent Vs. Non-Contingent Rewards: Time-Based Intervention Response Patterns Among Stimulant-Using Men Who Have Sex With Men. J Subst Abuse Treat. 2017 Jan;72:19-24. PMCID: PMC5922444.
- Passaro RC, Ramsey K, Segura ER, Lake JE, Reback CJ, Clark JL, Shoptaw S. Speed kills: Associations between methamphetamine use, HIV infection, tobacco use, and accelerated mortality among gay and bisexual men in Los Angeles, CA 20years after methamphetamine dependence treatment. Drug Alcohol Depend. 2019. 195:164-169. PMCID: PMC6512788